Viewing Study NCT01568060


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-03-06 @ 10:11 PM
Study NCT ID: NCT01568060
Status: COMPLETED
Last Update Posted: 2023-01-27
First Post: 2012-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module